Mass Balance Study
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293 (NCT02126514) | AstraZeneca | 2014-05-01 |
Track Mass Balance Study automatically
Every clearance here is in the API, with alerts when new ones post.